SCI Pharmtech Inc (4119) — Long-term Investment Intensity
SCI Pharmtech Inc (4119) has a Long-term Investment Intensity of 3.4% as of December 2019. Long-term investments of NT$137.33 Million represent 3.4% of total assets of NT$4.08 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 4119 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
SCI Pharmtech Inc Long-term Investment Intensity (2013–2019)
This chart shows how SCI Pharmtech Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 3.4%, reflecting long-term investments of NT$137.33 Million against total assets of NT$4.08 Billion TWD. Explore how well can SCI Pharmtech Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for SCI Pharmtech Inc (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for SCI Pharmtech Inc from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 4119 company net worth.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 3.4% | NT$137.33 Million | NT$4.08 Billion | ▲ +1.4 pp |
| 2018 | 2.0% | NT$75.30 Million | NT$3.79 Billion | ▲ +0.7 pp |
| 2017 | 1.3% | NT$42.37 Million | NT$3.30 Billion | ▲ +0.1 pp |
| 2016 | 1.2% | NT$42.37 Million | NT$3.55 Billion | ▼ 0.0 pp |
| 2015 | 1.2% | NT$42.37 Million | NT$3.46 Billion | ▼ -0.3 pp |
| 2014 | 1.6% | NT$50.09 Million | NT$3.22 Billion | ▲ +0.6 pp |
| 2013 | 1.0% | NT$29.87 Million | NT$3.05 Billion | — |